Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−13.01 EUR
−13.62 M EUR
0.00 EUR
1.34 M
About ACURX PHARMACEUTICALS INC
Sector
Industry
CEO
David P. Luci
Website
Headquarters
New York
Founded
2017
FIGI
BBG011M00224
Acurx Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company, which engages in developing new antibiotics for infections caused by bacteria listed as priority pathogens. Its approach is to develop antibiotic candidates that target the DNA polymerase IIIC enzyme. Its research and development pipeline includes early-stage antibiotic candidates that target other Gram-positive bacteria, including Methicillin-Resistant Staphylococcus aureus, Vancomycin-Resistant Enterococcus and Penicillin-Resistant Streptococcus pneumoniae. The company was founded by David P. Luci, Robert G. Shawah and Robert J. DeLuccia in July 2017 and is headquartered in New York, NY.
Related stocks
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange ACURX PHARMACEUTICALS INC stocks are traded under the ticker 3ZO0.
We've gathered analysts' opinions on ACURX PHARMACEUTICALS INC future price: according to them, 3ZO0 price has a max estimate of 138.09 EUR and a min estimate of 25.89 EUR. Watch 3ZO0 chart and read a more detailed ACURX PHARMACEUTICALS INC stock forecast: see what analysts think of ACURX PHARMACEUTICALS INC and suggest that you do with its stocks.
3ZO0 stock is 4.38% volatile and has beta coefficient of 1.55. Track ACURX PHARMACEUTICALS INC stock price on the chart and check out the list of the most volatile stocks — is ACURX PHARMACEUTICALS INC there?
Yes, you can track ACURX PHARMACEUTICALS INC financials in yearly and quarterly reports right on TradingView.
ACURX PHARMACEUTICALS INC is going to release the next earnings report on Aug 12, 2025. Keep track of upcoming events with our Earnings Calendar.
3ZO0 earnings for the last quarter are −2.03 EUR per share, whereas the estimation was −2.40 EUR resulting in a 15.38% surprise. The estimated earnings for the next quarter are −1.98 EUR per share. See more details about ACURX PHARMACEUTICALS INC earnings.
3ZO0 net income for the last quarter is −1.99 M EUR, while the quarter before that showed −2.69 M EUR of net income which accounts for 26.07% change. Track more ACURX PHARMACEUTICALS INC financial stats to get the full picture.
No, 3ZO0 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Aug 7, 2025, the company has 4 employees. See our rating of the largest employees — is ACURX PHARMACEUTICALS INC on this list?
Like other stocks, 3ZO0 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ACURX PHARMACEUTICALS INC stock right from TradingView charts — choose your broker and connect to your account.